FY 2026 Competitive Grant Solicitation Anti-Doping Activities

The Anti-Doping Activities grant is administered by the Executive Office of the President through the Office of National Drug Control Policy (ONDCP). This federal funding opportunity supports the United States’ ongoing commitment to maintaining the integrity and health of amateur athletics, particularly within Olympic, Pan American, and Paralympic competitions. The program is grounded in federal law, including the United States Anti-Doping Agency Reauthorization Act and the Consolidated Appropriations Act, and aligns with national priorities to eliminate performance-enhancing drug use in sport. ONDCP serves as the coordinating body responsible for awarding funds to an eligible entity capable of carrying out nationwide anti-doping responsibilities. The primary purpose of this grant is to provide continued and comprehensive support for anti-doping activities across the United States. These activities include athlete drug testing, research initiatives, educational programming, and enforcement mechanisms designed to uphold compliance with the World Anti-Doping Code. The selected grantee will play a central role in ensuring that athletes are informed about prohibited substances, understand the risks associated with doping, and are subject to fair and consistent testing and adjudication processes. The program also emphasizes legal support for enforcing anti-doping rules and managing appeals related to violations. Funding under this opportunity is expected to support a wide range of allowable activities. These include operational costs associated with testing programs, development and dissemination of educational materials, research into anti-doping methodologies, and legal processes tied to enforcement and adjudication. Budget submissions must be detailed and cover categories such as personnel, travel, equipment, and specialized costs like international testing and logistical support. While there is no cost-sharing requirement, expenditures must comply with federal cost principles and be reasonable, necessary, and allocable to program objectives. Eligibility for this grant is highly specific and limited to organizations that meet strict criteria. Applicants must serve as the independent national anti-doping organization for amateur athletic competitions recognized by the United States Olympic and Paralympic Committee. They must also be responsible for certifying international testing within U.S. jurisdiction and be globally recognized in this role. Additionally, applicants must demonstrate the ability to coordinate with international anti-doping organizations and provide proof of recognition by the U.S. Olympic and Paralympic Committee. This effectively limits eligibility to a single qualified entity with national authority and established expertise. The application process requires submission through Grants.gov and includes several mandatory components such as the SF-424 forms, a program narrative, and a detailed budget narrative. Applicants must also maintain active registration in the System for Award Management (SAM) and provide a valid Unique Entity Identifier. The program narrative must address technical expertise, program design, and alignment with ONDCP objectives, while also adhering to formatting requirements. Applications are evaluated based on criteria including program design, organizational capabilities, budget justification, and performance measurement strategies. The application deadline is June 22, 2026, at 5:00 PM Eastern Time. ONDCP encourages early submission to allow time for validation and correction of any issues. The agency expects to make a single award in July 2026, with funding totaling approximately $14,000,000. Following award, the recipient must comply with federal reporting requirements, including quarterly performance and financial reports. The grant does not indicate a recurring cycle and appears to be a one-time competitive solicitation, although similar funding may be issued in future appropriations cycles.

Ensure strong demonstration of anti-doping expertise, clearly defined program design with timelines, and measurable performance outcomes aligned with ONDCP priorities